APA (7th ed.) Citation

Ghang, B., Kwon, O., Hong, S., Lee, C., Yoo, B., & Kim, Y. (2017). Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy. Modern rheumatology, 27(3), 405-410. https://doi.org/10.1080/14397595.2016.1214340

Chicago Style (17th ed.) Citation

Ghang, Byeongzu, Ohchan Kwon, Seokchan Hong, Chang-Keun Lee, Bin Yoo, and Yong-Gil Kim. "Neutrophil-to-lymphocyte Ratio Is a Reliable Marker of Treatment Response in Rheumatoid Arthritis Patients During Tocilizumab Therapy." Modern Rheumatology 27, no. 3 (2017): 405-410. https://doi.org/10.1080/14397595.2016.1214340.

MLA (9th ed.) Citation

Ghang, Byeongzu, et al. "Neutrophil-to-lymphocyte Ratio Is a Reliable Marker of Treatment Response in Rheumatoid Arthritis Patients During Tocilizumab Therapy." Modern Rheumatology, vol. 27, no. 3, 2017, pp. 405-410, https://doi.org/10.1080/14397595.2016.1214340.